Anaplastic Astrocytoma

general

A diffusely infiltrating, WHO grade 3 astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)

65

Centers

183

Active Trials

$2M

Cancer Funding

Specific Cancer Types(1)

Top Centers for Anaplastic Astrocytoma(65)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
87.0
2
NCI Clinical
High-Volume Research Center
85.5
3
NCI Comprehensive
High-Volume Research Center
85.4
4
High-Volume Research Center
70.8
5
High-Volume Research Center
70.8
6
High-Volume Research Center
70.8
7
High-Volume Research Center
70.8
8
NCI Comprehensive
Active Research Program
69.3
9
NCI Comprehensive
Active Research Program
66.7
10
NCI Comprehensive
Active Research Program
66.7
11
NCI Comprehensive
Active Research Program
64.2
12
Active Research Program
64.2
13
NCI Clinical
Active Research Program
64.2
1464.2
15
Active Research Program
64.2
16
NCI Comprehensive
Active Research Program
52.1
17
NCI Comprehensive
Active Research Program
52.1
18
NCI Comprehensive
Active Research Program
52.1
19
NCI Comprehensive
Active Research Program
52.1
20
NCI Comprehensive
Active Research Program
52.1
21
NCI Comprehensive
Active Research Program
52.1
22
NCI Comprehensive
Active Research Program
52.1
23
NCI Comprehensive
Active Research Program
52.1
24
NCI Comprehensive
Active Research Program
52.1
25
NCI Comprehensive
Active Research Program
52.1
2652.1
27
NCI Comprehensive
Active Research Program
52.1
28
NCI Comprehensive
Active Research Program
52.1
29
NCI Comprehensive
Active Research Program
52.1
30
Active Research Program
52.1
31
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
52.1
32
NCI Comprehensive
Active Research Program
52.1
33
NCI Comprehensive
Active Research Program
52.1
34
NCI Comprehensive
Active Research Program
52.1
35
NCI Clinical
Active Research Program
52.1
36
Active Research Program
52.1
37
Active Research Program
52.1
38
Active Research Program
52.1
3952.1
40
Active Research Program
52.1
41
Active Research Program
52.1
42
BC CancerVancouver, BC
Active Research Program
52.1
43
Active Research Program
52.1
44
Active Research Program
52.1
45
NCI Comprehensive
Active Research Program
38.3
46
NCI Comprehensive
Active Research Program
38.3
47
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
38.3
48
NCI Clinical
Active Research Program
38.3
49
Active Research Program
38.3
50
NCI Comprehensive
Active Research Program
38.3
51
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
38.3
52
NCI Comprehensive
Active Research Program
38.3
53
NCI Comprehensive
Active Research Program
38.3
54
Active Research Program
38.3
55
NCI Comprehensive
31.0
56
NCI Comprehensive
31.0
57
NCI Comprehensive
31.0
5831.0
59
NCI Comprehensive
31.0
60
NCI Comprehensive
31.0
61
NCI Clinical
31.0
62
NCI Comprehensive
31.0
6331.0
6431.0
6531.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →